BACKGROUND: Erectile dysfunction (ED) is associated with an increased risk for cardiovascular disease, stroke, and all-cause mortality, independent of conventional cardiovascular risk factors. Coronary endothelial dysfunction is independently associated with ED in men with early coronary atherosclerosis. We aimed to investigate whether coronary microvascular dysfunction predicts development of ED in patients presenting with coronary atherosclerosis without critical stenoses. PATIENTS AND METHODS: Coronary microvascular function was evaluated in 130 men with coronary atherosclerosis without critical stenoses by administration of intracoronary acetylcholine at the time of diagnostic study. After a mean follow-up of 8.4 years, patients were assessed for the development of ED by administration of a questionnaire. RESULTS: In all, 68 (50%) men had microvascular endothelial dysfunction at baseline; 35 (51%) men with microvascular endothelial dysfunction developed ED on follow-up compared with 19 (31%) men without microvascular endothelial dysfunction. Men who developed ED had a lower coronary blood flow response (% [INCREMENT]CBF) compared with men who did not develop ED, with mean±SD of 25.4±71.3 versus 81.7±120 (P=0.003). In univariate analysis, microvascular endothelial dysfunction was a predictor for the development of ED, with relative risk of 2.4 (1.2-4.9) (P=0.016). In multivariate logistic regression adjusting for traditional cardiovascular risk factors (age, hypertension, hyperlipidemia, diabetes, vascular disease, and family history of coronary artery disease), only microvascular endothelial dysfunction (P=0.027) and age (P=0.044) remained significant predictors of development of ED. CONCLUSION: Coronary microvascular dysfunction is a predictor of the development of ED in men with coronary atherosclerosis without critical stenoses. This study underscores the systemic involvement of the endothelial function in vascular disease.
BACKGROUND:Erectile dysfunction (ED) is associated with an increased risk for cardiovascular disease, stroke, and all-cause mortality, independent of conventional cardiovascular risk factors. Coronary endothelial dysfunction is independently associated with ED in men with early coronary atherosclerosis. We aimed to investigate whether coronary microvascular dysfunction predicts development of ED in patients presenting with coronary atherosclerosis without critical stenoses. PATIENTS AND METHODS: Coronary microvascular function was evaluated in 130 men with coronary atherosclerosis without critical stenoses by administration of intracoronary acetylcholine at the time of diagnostic study. After a mean follow-up of 8.4 years, patients were assessed for the development of ED by administration of a questionnaire. RESULTS: In all, 68 (50%) men had microvascular endothelial dysfunction at baseline; 35 (51%) men with microvascular endothelial dysfunction developed ED on follow-up compared with 19 (31%) men without microvascular endothelial dysfunction. Men who developed ED had a lower coronary blood flow response (% [INCREMENT]CBF) compared with men who did not develop ED, with mean±SD of 25.4±71.3 versus 81.7±120 (P=0.003). In univariate analysis, microvascular endothelial dysfunction was a predictor for the development of ED, with relative risk of 2.4 (1.2-4.9) (P=0.016). In multivariate logistic regression adjusting for traditional cardiovascular risk factors (age, hypertension, hyperlipidemia, diabetes, vascular disease, and family history of coronary artery disease), only microvascular endothelial dysfunction (P=0.027) and age (P=0.044) remained significant predictors of development of ED. CONCLUSION:Coronary microvascular dysfunction is a predictor of the development of ED in men with coronary atherosclerosis without critical stenoses. This study underscores the systemic involvement of the endothelial function in vascular disease.
Authors: G Jackson; N Boon; I Eardley; M Kirby; J Dean; G Hackett; P Montorsi; F Montorsi; C Vlachopoulos; R Kloner; I Sharlip; M Miner Journal: Int J Clin Pract Date: 2010-06 Impact factor: 2.503
Authors: C M Moinpour; L C Lovato; I M Thompson; J E Ware; P A Ganz; D L Patrick; S A Shumaker; G W Donaldson; A Ryan; C A Coltman Journal: J Clin Oncol Date: 2000-05 Impact factor: 44.544
Authors: Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi Journal: Circulation Date: 2002-08-06 Impact factor: 29.690
Authors: Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman Journal: Hypertension Date: 2016-12-19 Impact factor: 10.190
Authors: Megha Prasad; Jaskanwal Sara; Robert J Widmer; Ryan Lennon; Lilach O Lerman; Amir Lerman Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Ibrahim Yildiz; Fatih Gokalp; Cengiz Burak; Sinan Karazindiyanoglu; Pinar Ozmen Yildiz; Ibrahim Rencuzogullari; Yavuz Karabag; Metin Cagdas Journal: J Tehran Heart Cent Date: 2020-07
Authors: Mustapha Ahsaini; Jean Paul Omana; Soufiane Mellas; Jalal Eddine El Ammari; Mohammed Fadl Tazi; Mohammed Jamal El Fassi; Moulay Hassan Farih Journal: Pan Afr Med J Date: 2020-10-30
Authors: Weslley Santiago Andrade; Paulo Oliveira; Humberto Laydner; Eduardo José Pereira Ferreira; Jose Augusto Soares Barreto-Filho Journal: Int Braz J Urol Date: 2016 Jan-Feb Impact factor: 1.541
Authors: Osman Bektaş; Ahmet Karagöz; Adil Bayramoğlu; Erdal Benli; Zeki Yüksel Günaydın; Mehmet Yaman; Ahmet Kaya Journal: Acta Cardiol Sin Date: 2018-11 Impact factor: 2.672